TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression

10.18632/oncotarget.4583

Saved in:
Bibliographic Details
Main Authors: Ho, V, Lim, T.S, Lee, J, Steinberg, J, Szmyd, R, Tham, M, Yaligar, J, Kaldis, P, Abastado, J.-P, Chew, V
Other Authors: BIOCHEMISTRY
Format: Article
Published: 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/174138
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore